New Antifungal Drugs, New Approaches and Vaccines

In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections

22 January 2014

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids

23 June 2015

Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans

23 March 2000

Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei

19 March 2003

Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species

20 February 2003

The immunosuppressant FK506 (tacrolimus) and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein

11 January 1997

Inhibitors of fungal GWT1 and MCD4 discovered through Candida albicans fitness test

8 September 2014

Inhibitors of fungal GWT1 and MCD4 discovered through Candida albicans fitness test

8 September 2014

Inhibitors of fungal GWT1 and MCD4 discovered through Candida albicans fitness test

11 October 2017

Drugs in Clinical Development for Fungal Infections (includes MAT023, encochleated amphotericin B))

24 August 2017